Intellepedia | IP News Center

Justice Pratibha M. Singh of Delhi High Court to Chair WIPO’s Advisory Board of Judges

Justice Pratibha M. Singh will head WIPO’s Advisory Board of Judges (2025–2027), reflecting India’s assured stride in global IP jurisprudence.

Infrared-Based Biomolecule Detection is Not excluded under Section 3(i) of the Patents Act: Delhi HC

Close-up of a metallic microscope lens projecting an infrared beam onto stylized chemical structures, with DNA-like strands and an “IR” graph on a dark background.

In the case of EMD Millipore Corporation vs Assistant Controller of Patents and Designs, the Delhi High Court held that a non-invasive method for analysing biomolecules is not excluded from patentability under Section 3(i). The Court allowed the applicant to revert to earlier claims and upheld the right to amend claims in appeal.

Creating Similar Voices with AI Infringes Celebrity Rights, Kumar Sanu Case Confirms

In the case of Kumar Sanu Bhattacharjee vs Jammable Limited & Ors, the Delhi High Court restrained multiple AI platforms and online intermediaries from creating or circulating synthetic audio mimicking Kumar Sanu’s voice as well as other aspects of his persona. The court found that voice forms part of a celebrity’s personality along with other characteristics, and cannot be used without authorisation.

Court Upholds Hi-Tech Arai’s Claim In HTA Trademark Dispute

Automotive factory with machinery and rubber oil seals in the foreground.

The Delhi High Court upheld Hi-Tech Arai’s claim in the HTA trademark dispute, granting an interim injunction against the defendants for dishonest adoption and use of fabricated evidence. The decision emphasises the significance of continuous and bona fide use in Indian trademark law.

Come On Barbie, Let Us Stop the Trademark Party

In the case of Mattel, Inc. vs. Padum Borah & Ors, the Delhi High Court barred the use of the word ‘BARBIE’ by a hospitality business, holding that the use of the iconic trademark for unrelated services was likely to cause confusion and dilute the brand. The Court observed that the Defendant’s use of identical marks with stylized pink logos constituted dishonest adoption and granted an injunction to protect the Plaintiff’s rights.

Section 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing Method

DNA gel bands with a magnifying glass highlighting DNA bases and the word “Disease

Delhi HC rules Sequenom’s NIPT methods are excluded as “diagnostic” under Section 3(i) and hit by 3(b) for sex selection concerns, while keeping the door open for tools and products.

What’s Not Confidential Can’t Be Protected: No Injunction for Disclosed Customer Data

In the case of Indrex Private Limited vs Suresh Balasubramanian, the Bombay High Court examined whether customer information held by a former employee remained confidential after termination of a cooperation agreement. The plaintiff sought an injunction to restrain use of such information, but the Court declined, finding that the cooperation terms required disclosure and permitted lawful use by the business partner’s successor.

Patent Associate Openings at BananaIP – Mechanical & Electronics

Patent Associate Job Openings at BananaIP

Openings for Patent Associates in Mechanical and Electronics at BananaIP, Bangalore—drafting, prosecution, and tech analysis for serious innovators. Apply via hr@bananaip.com.

Personality Rights Infringement via Deepfakes and Digital Misuse

Concept image showing legal balance scales and a gavel symbolizing justice, with a shadowed human figure in the background and a laptop displaying digital media icons and the text 'Safeguarding personality rights in the age of AI and deepfakes'.

The Bombay High Court’s decision in Suniel Shetty vs John Doe addresses personality rights infringement caused by deepfakes and digital misuse. The judgement clarifies the scope of legal remedies for celebrities and the obligations of online platforms under Indian law.

Roche’s Appeal Dismissed, Path Open for Affordable Risdiplam in India

Illustration of a medicine bottle labeled “Risdiplam” next to the word “unaffordable,” with a hand using scissors to cut off the “un” prefix, symbolizing making the drug affordable.

The Delhi High Court dismissed Roche’s appeal against Natco Pharma, finding the Risdiplam patent prima facie obvious due to its similarity with prior genus patents, paving the way for affordable generic SMA treatment in India.